Medical Developments International Share Price and Company Fundamentals
Last traded: Today at 3:31 AM
Medical Developments International Limited manufactures and distributes emergency medical solutions in Australia, Asia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It offers Penthrox, a trauma and emergency pain relief product for use in hospitals, emergency departments, ambulance services, sport medicines, and for analgesia during short procedures. The company also distributes asthma and chronic obstructive pulmonary disease products, such space chambers, peak flow meters, portable nebulisers, and silicon face mask. Medical Developments International Limited was founded in 1972 and is headquartered in Scoresby, Australia.
Key Metrics
PE ratio
Infinity
PB ratio
0.98
Dividend yield
-
Beta
1.44
Market cap
$54.08M
Enterprise value
$38.79M
Company profile
| Industry / Sector | Drug Manufacturers - Specialty & Generic / Healthcare |
|---|---|
| Website | https://medicaldev.com |
| Mailing address | 4 Caribbean Drive Scoresby VIC 3179 Australia |
| Phone / Fax | 61 3 9547 1888 / 61 3 9547 0262 |
Dividends
More: Medical Developments International Dividend history, yield and payout ratio
Dividend yield
-
Dividend amount
$-
Payout ratio
0.00%
5Y Avg. yield
-%
Medical Developments International paid $- dividend and the ex-dividend date was 05 Mar 2020.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.MVP dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Feb 2026, following are the company executives and directors listed on Medical Developments International.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Brent MacGregor | Chief Executive Officer | 61 | |
| Ms. Anita James | Chief Financial Officer | ||
| Ms. Anastasia Tan | Head of Operations & Supply Chain | ||
| Dr. Scott Courtney | Chief Scientific Officer | ||
| Ms. Tara Eaton L.L.B., L.L.M. | General Counsel & Company Secretary | ||
| Mr. Anthony Wheal | Head of People & Culture | ||
| Wayne Pearce | Head of Production | ||
| Mr. Stefaan Schatteman | Head of Europe | ||
| Ms. Julianne Alexander | Head of Medical Affairs & Clinical Development | ||
| Mr. Jas Singh | Global Head of Respiratory |
Profitability and management effectiveness
Profit margin
0.24%
Operating margin
-5.04%
Return on assets
0.14%
Return on equity
0.19%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Medical Developments International is 54.08M and its enterprise value is 38.79M. The enterprise value to revenue ratio of MVP is 0.99. The enterprise value to EBITDA ratio of MVP is 23.17.
The MVP's stocks Beta value is 1.44 making it 44% more volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Medical Developments International (MVP)
Medical Developments International (ASX:MVP) Frequently Asked Questions
1. What is Medical Developments International's Stock Symbol?
Medical Developments International trades on ASX under the ticker symbol "MVP".
2. What is Medical Developments International's stock price today?
One share of MVP stock can currently be purchased for approximately $0.48.
3. How can I contact Medical Developments International?
Medical Developments International's mailing address is 4 Caribbean Drive Scoresby VIC 3179 Australia. The company can be reached via phone at 61 3 9547 1888.
4. What is Medical Developments International's official website?
The official website of Medical Developments International is https://medicaldev.com.